These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9436633)

  • 1. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer.
    Hochhauser D
    Anticancer Drugs; 1997 Nov; 8(10):903-10. PubMed ID: 9436633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
    Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
    J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.
    King TC; Estalilla OC; Safran H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):4-11. PubMed ID: 10210535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
    Biernat W; Tohma Y; Yonekawa Y; Kleihues P; Ohgaki H
    Acta Neuropathol; 1997 Oct; 94(4):303-9. PubMed ID: 9341929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
    Uno M; Otsuki T; Hiratsuka J; Yoden E; Aihara T; Harada T; Imajo Y
    Int J Oncol; 2000 Nov; 17(5):947-54. PubMed ID: 11029497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of cell cycle-regulatory genes in prostate cancer.
    Fernández PL; Hernández L; Farré X; Campo E; Cardesa A
    Pathobiology; 2002; 70(1):1-10. PubMed ID: 12415186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
    Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
    Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
    Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation.
    Tabach Y; Milyavsky M; Shats I; Brosh R; Zuk O; Yitzhaky A; Mantovani R; Domany E; Rotter V; Pilpel Y
    Mol Syst Biol; 2005; 1():2005.0022. PubMed ID: 16729057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
    Reed MF; Zagorski WA; Knudsen ES
    J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.
    Pei XF
    Carcinogenesis; 1996 Jul; 17(7):1395-401. PubMed ID: 8706240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle deregulation: a common motif in cancer.
    Malumbres M; Carnero A
    Prog Cell Cycle Res; 2003; 5():5-18. PubMed ID: 14593696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of apoptotic response in cellular resistance to cytotoxic agents.
    Zunino F; Perego P; Pilotti S; Pratesi G; Supino R; Arcamone F
    Pharmacol Ther; 1997; 76(1-3):177-85. PubMed ID: 9535179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.